Latest news
Insulet (PODD) Is Down 15.9% After Cutting 2026 Revenue Guidance on Type 2 Retention Strains - webull.comwebull.com · Mon, 10 Aug 2026 08:52:03 GMTIs Siemens Healthineers (XTRA:SHL) Undervalued After Cutting Its 2026 Revenue Growth Outlook? - simplywall.stsimplywall.st · Mon, 10 Aug 2026 06:33:45 GMTWhy Sarepta Therapeutics (SRPT) Is Up 12.9% After Cutting 2026 Guidance And Naming A New CEO - simplywall.stsimplywall.st · Mon, 10 Aug 2026 05:32:52 GMTOrganogenesis Holdings (ORGO) After Earnings Cut, Guidance Reset And $75 Million Raise, Still A Bargain? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 23:38:59 GMTWhy Flutter Entertainment (FLUT) Is Down 9.3% After Cutting 2026 Guidance And Announcing CEO Transition - simplywall.stsimplywall.st · Sun, 09 Aug 2026 21:26:55 GMTBioNTech (BNTX) Cuts 2026 Guidance On An Undervalued Story Or Fair Warning - simplywall.stsimplywall.st · Sun, 09 Aug 2026 13:52:53 GMTEdison International (EIX) Is Down 6.5% After Cutting 2026 EPS Guidance Despite Higher Q2 Profit - Has The Bull Case Changed? - simplywall.stsimplywall.st · Sun, 09 Aug 2026 04:21:48 GMTDid Stronger Q2 Earnings and Lowered 2026 Guidance Just Recast Exelixis' (EXEL) Oncology Narrative? - simplywall.stsimplywall.st · Sat, 08 Aug 2026 18:39:21 GMT